Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine Detailed results from completed Phase 1b/2a trial of ACI-35.030 and JACI-35.054 ...

By geographic region, the revenue of the EMEA region amounted to €169.6 million in the first half of 2025, down 7.7% at CER and like-for-like. Excluding France, revenue grew 6.9% at CER and ...

Patients achieve consistent results as CaptivatingU Med Spa provides Botox in Cincinnati with one board-certified specialist ...

Widely regarded as arguably the best OTC fat burner and appetite suppressant pill, PhenQ helps users tackle fat loss from ...

Cash and cash equivalents totaled €107.5 million as of June 30, 2025, excluding the €26.5 million milestone invoiced in May 2025 (received in ...

The Neuromodulation Market is witnessing significant momentum due to the growing prevalence of chronic disorders, ...

Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study ...

The hormone once associated with hugs and trust is now at the forefront of research on stress, adaptation, and the ...

Do red light neck devices really work? Shop the best expert-recommended and editor-tested red light neck products from Amazon ...

How coercive control restructures attachment, exploits social systems, and traps victims in conditions that mimic consent but ...

Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programmePositive results show that the average weight loss was 12.5 kg (11.8 ...